JL Fahey
Impact in
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Virology top 5%
- HIV Research and Treatment
Papers in
- Hematology 10
- Hematopoietic Stem Cell Transplantation 9
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 3
- Virology 2
- HIV Research and Treatment 2
- Journals
- Blood (11 papers)PubMed (6 papers)
- Partner nations
- United States
In The Last Decade
JL Fahey
17 papers receiving 687 citations
Peers
Comparison fields: 5 of 58
- Hematology 397
- Virology 128
- Genetics 147
- Immunology 162
- Public Health, Environmental and Occupational Health 209
Countries citing papers authored by JL Fahey
This map shows the geographic impact of JL Fahey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JL Fahey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JL Fahey more than expected).
Fields of papers citing papers by JL Fahey
This network shows the impact of papers produced by JL Fahey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JL Fahey. The network helps show where JL Fahey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside JL Fahey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 18 | |
| 2 | Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS. | 1989 | 85 |
| 3 | Patterns of CD4+ cell changes after HIV-1 infection indicate the existence of a codeterminant of AIDS. | 1988 | 46 |
| 4 | 1987 | 6 | |
| 5 | Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphoma. | 1987 | 16 |
| 6 | 1987 | 139 | |
| 7 | 1987 | 94 | |
| 8 | 1986 | 66 | |
| 9 | 1986 | 1 | |
| 10 | Suppression of natural killer cell cytotoxicity in the peripheral blood of patients receiving interferon therapy. | 1983 | 15 |
| 11 | 1983 | 54 | |
| 12 | 1983 | 38 | |
| 13 | 1982 | 109 | |
| 14 | 1982 | 2 | |
| 15 | 1982 | 43 | |
| 16 | Bone marrow ablation and marrow transplantation in acute leukemia: influence of clinical pretransplant condition. | 1981 | 3 |
| 17 | Bone marrow transplantation as the treatment of choice for "good risk" adult patients with acute leukemia. | 1979 | 17 |
About JL Fahey
JL Fahey is a scholar working on Hematology, Virology, Emergency Medicine, Oncology and Orthopedics and Sports Medicine, having authored 17 papers that have together received 752 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (9 papers), Immune Cell Function and Interaction (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Polyomavirus and related diseases (3 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Hematology (397 citations), Virology (128 citations), Genetics (147 citations), Immunology (162 citations) and Public Health, Environmental and Occupational Health (209 citations). JL Fahey has collaborated with scholars based in United States. Frequent co-authors include KG Blume, AP Nademanee, KA Foon, RW Schroff, MR O’Donnell, DS Snyder, GM Schmidt, SJ Forman, RA Krance and Roger Detels. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.